Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Inovio Pharma (NQ: INO )

11.10 USD -0.39 (-3.39%)
Official Closing Price Updated: 7:59 PM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Inovio Pharma

< Previous 1 2
...
18 19 20 21 22 23 24 25 Next >
Inovio Pharmaceuticals Reports 2015 Second Quarter Results; Conference Call Will Discuss New Cancer Partnership
Go to inovio.com at 8:30 a.m. ET Today and Click on "Webcast" to Join the Call 
From GlobeNewswire News Releases
Inovio Pharmaceuticals Enters Into Strategic Cancer Vaccine Collaboration and License Agreement With MedImmune
From GlobeNewswire News Releases
Critical Alerts For Juno Therapeutics Inc, Inovio Pharmaceuticals, Microsoft, Yahoo! and Vivint Solar Inc Released By InvestorsObserver
From PR Newswire
Inovio Pharmaceuticals to Host Second Quarter 2015 Financial Results Conference Call August 10, 2015
From GlobeNewswire News Releases
Inovio Pharmaceuticals' DNA-Based Monoclonal Antibody Protects Animals Against Lethal Challenge
From GlobeNewswire News Releases
Inovio Pharmaceuticals Initiates Clinical Trial of INO-5150 DNA Immunotherapy for Prostate Cancer
Inovio's Focus on Taking Immunotherapy to the Next Level Expands Into Prostate Cancer 
From GlobeNewswire News Releases
Inovio Pharmaceuticals and European Organization for Research and Treatment of Cancer to Collaborate on Large Phase II Cervical Cancer Trial
Partnership With Europe's Largest Cancer Research Organization Will Benefit Inovio in Faster European Recruiting and Clinical Results 
From GlobeNewswire News Releases
Inovio's CEO Appointed to Aspen Institute's Health Innovators Fellowship
Immunotherapy Pioneer Will Work With Other Business and Medical Leaders to Create New Approaches to Improve Healthcare 
From GlobeNewswire News Releases
Rodman & Renshaw 2015 Annual Global Investment Conference to be held in New York from September 8 to 10, 2015
From PR Newswire
Critical Alerts For Alcoa, VASCO Data Security, Zillow, Inovio Pharmaceuticals and Kite Pharma Released By InvestorsObserver
From PR Newswire
Inovio Pharmaceuticals CEO Named "Entrepreneur of the Year" by Ernst & Young
Dr. J. Joseph Kim Selected for Philadelphia Region Award 
From GlobeNewswire News Releases
Critical Alerts For Abercrombie & Fitch, Inovio Pharmaceuticals, Wynn Resorts, Mylan and Netflix Released By InvestorsObserver
From PR Newswire
Inovio Pharmaceuticals Partners with GeneOne Life Science for MERS Immunotherapy Clinical Development
Lethal Middle East Respiratory Syndrome Kills 40% of Those Infected; Human-to-Human Transmission of the Virus has Occurred in South Korea 
From GlobeNewswire News Releases
Inovio to Present at Jefferies Healthcare Conference
From GlobeNewswire News Releases
Critical Alerts For Apple, Freeport-McMoRan, Celgene, Inovio Pharmaceuticals and Ambarella Released By InvestorsObserver
From PR Newswire
Critical Alerts For Inovio Pharmaceuticals, TrueCar, HealthStream, Nuance Communications and Kinder Morgan Released By InvestorsObserver
From PR Newswire
Inovio Initiates Clinical Trial With DNA Immunotherapies to Prevent and Treat Ebola
First Step in DARPA-Funded $45 Million Program 
From GlobeNewswire News Releases
Inovio Pharmaceuticals Reports 2015 First Quarter Financial Results
From GlobeNewswire News Releases
Inovio Pharmaceuticals Closes $87.4 Million Underwritten Financing
From GlobeNewswire News Releases
Inovio Pharmaceuticals to Report First Quarter 2015 Financial Results May 11, 2015
From GlobeNewswire News Releases
Inovio Pharmaceuticals Announces Pricing of Public Offering of Common Stock
From GlobeNewswire News Releases
Inovio Pharmaceuticals Announces Public Offering of Common Stock
From GlobeNewswire News Releases
Critical Alerts For Inovio Pharmaceuticals, Hong Kong Television Network, Juniper Networks, United Rentals and Archer-Daniels-Midland Released By InvestorsObserver
From PR Newswire
Inovio Pharmaceuticals and Roche Initiate Clinical Trial for Inovio's DNA Immunotherapy to Treat Chronic Hepatitis B Infection
From GlobeNewswire News Releases
All Penny Stocks.com News: More Strides Made in Protecting Against Ebola Virus
Mississauga, ON -- (ReleaseWire) -- 04/09/2015 -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled "More Strides Made in Protecting Against Ebola... 
From SBWire - Latest Press Releases
Inovio Pharmaceuticals' HPV Immunotherapy Recognized as "Best Therapeutic Vaccine" by World Vaccine Congress
Inovio's Co-Founder and Chair of Its Scientific Board -- Dr. David B. Weiner's Lab Named "Best Academic Research Team" 
From GlobeNewswire News Releases
Critical Alerts For Inovio Pharmaceuticals, Perrigo Co., Weibo, Regulus Therapeutics and Qihoo 360 Technology Released By InvestorsObserver
From PR Newswire
Leading Biotech Companies Seek Biologic Treatments for Rare Diseases Utilizing Viable Therapeutic Approach - Company Receives FDA Orphan Drug Designation for Bryostatin
From PR Newswire
Inovio Pharmaceuticals HPV Immunotherapy Activates Robust In Vivo T Cell Responses in Head & Neck Cancer Patients
DNA-Based Immunotherapy Generates Strong Immune Responses Similar to Those in Patients Treated for Cervical Dysplasia 
From GlobeNewswire News Releases
Inovio Pharmaceuticals Selected by DARPA to Lead a $45 Million Program to Expedite Development of Novel Products to Prevent and Treat Disease Caused by Ebola
Funding Will Accelerate Development of Inovio's DNA-Based Monoclonal Antibodies That Could Offer Product Development, Manufacturing, Scale-Up and Dosing Benefits 
From GlobeNewswire News Releases
< Previous 1 2
...
18 19 20 21 22 23 24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.